(Stroke. 1999;30:171-179.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Clinical Neurologica, Dip. Neuroscienze, Università di Roma Tor Vergata (P.C., G.A.M., D.C., A.P., G.B.) and IRCCS, S. Lucia (G.B.), Rome, Italy.
Correspondence to Dr. P. Calabresi, Clinica Neurologica, Università di Roma Tor Vergata, Dip. Neuroscienze, Via di Tor Vergata, 135-00133, Rome, Italy.
| Abstract |
|---|
|
|
|---|
MethodsWe studied the effects of in vitro ischemia (oxygen and glucose deprivation) at the cellular level using intracellular recordings and microfluorometric measurements in a slice preparation. We also used various channel blockers and pharmacological compounds to characterize the ischemia-induced ionic conductances.
ResultsSpiny neurons responded to ischemia with a membrane depolarization/inward current that reversed at approximately -40 mV. This event was coupled with an increased membrane conductance. The simultaneous analysis of membrane potential changes and of variations in [Na+]i and [Ca2+]i levels showed that the ischemia-induced membrane depolarization was associated with an increase of [Na+]i and [Ca2+]i. The ischemia-induced membrane depolarization was not affected by tetrodotoxin or by glutamate receptor antagonists. Neither intracellular BAPTA, a Ca2+ chelator, nor incubation of the slices in low-Ca2+containing solutions affected the ischemia-induced depolarization, whereas it was reduced by lowering the external Na+ concentration. High doses of blockers of ATP-dependent K+ channels increased the membrane depolarization observed in spiny neurons during ischemia.
ConclusionsOur findings show that, although the ischemia-induced membrane depolarization is coupled with a rise of [Na+]i and [Ca2+]i, only the Na+ influx plays a prominent role in this early electrophysiological event, whereas the increase of [Ca2+]i might be relevant for the delayed neuronal death. We also suggest that the activation of ATP-dependent K+ channels might counteract the ischemia-induced membrane depolarization.
Key Words: brain ion channels oxygen glucose neuroprotection rats
| Introduction |
|---|
|
|
|---|
Recent experimental findings have shown that Na+-channel blockers reduce ischemia-induced cortical neuronal injury when combined with glutamate receptor antagonists.3 Moreover, microfluorometric studies have demonstrated that anoxia induces an increase in [Na+]i in rat CA1 hippocampal neurons.4 The mechanisms underlying the sustained neuronal penetration of Na+ during ischemia are still unclear. In fact, the classic voltage-gated Na+ channels that initiate the action potential rapidly inactivate during ischemic depolarization,5 suggesting that their contribution to the ischemic event is unlikely. Alternatively, it is possible that the rise in [Na+]i during ischemia is due either to the activation of non-NMDA glutamate receptors or to the opening of non-inactivating Na+ channels.3
Despite this large body of evidence, the relative contribution of Na+ and Ca2+ ions to the ischemic depolarization has never been simultaneously investigated in the same neuronal subtype. Moreover, although several pharmacological compounds that act on Na+ and Ca2+ channels have been tested in experimental models of ischemia,1 3 5 the effects of these putative neuroprotective agents have never been analyzed at the cellular level on the electrophysiological events caused by ischemia in brain slices. In the present study, we used a brain slice preparation to characterize the effects of in vitro ischemia on striatal spiny neurons intracellularly recorded. In some experiments, the electrophysiological recordings have been combined with microfluorometric measurements of [Na+]i and [Ca2+]i. To address the differential contribution of these ions to the ischemia-induced depolarization, various experimental approaches have been used: (1) ionic substitutions in the external medium, (2) application of selective blockers of Na+ and Ca2+ channels, (3) intracellular injection of a Ca2+-chelating agent, (4) application of ionotropic glutamate receptor antagonists, (5) application of drugs that in other experimental models of ischemia have shown a neuroprotective action via the inhibition of Na+ and Ca2+ channels, and (6) use of blockers of ATP-dependent K+ channels to test the possible involvement of other ionic conductances in this electrophysiological event.6
| Materials and Methods |
|---|
|
|
|---|
Recording Technique
In most of the experiments, the intracellular recording
electrodes were filled with 2 mol/L KCl (30 to 60 M
). In other
experiments 200 mmol/L BAPTA was added to the solution of the
intracellular pipette to buffer intracellular
Ca2+. In a third group of experiments, the
pipettes were filled with 2 mol/L potassium acetate. An Axoclamp 2A
amplifier (Axon Instruments) was used for recordings, either in
current-clamp or in voltage-clamp mode. In single-electrode
voltage-clamp mode the switching frequency was 3 kHz. The head-stage
signal was continuously monitored on a separate oscilloscope. Traces
were displayed on an oscilloscope and stored on a digital system. For
synaptic stimulation, bipolar electrodes were used. These stimulating
electrodes were located either in the cortical areas close to the
recording electrode or in the white matter between the cortex
and the striatum to activate corticostriatal fibers. In some
experiments, biocytin (Sigma) was used in the intracellular electrode
to stain the neurons. In these cases, biocytin at a concentration of
2% to 4% was added to a 0.5 mol/L KCl pipette solution. Slices
containing neurons stained with biocytin were fixed in
paraformaldehyde (in 0.1 mol/L phosphate buffer at pH
7.4) overnight and processed according to published
protocols.14 After incubation in phosphate buffer
containing 30% sucrose for 3 hours, the slices were frozen and further
resectioned in a cryostat at a thickness of 40 µm. In several
cases, sections were further processed to make permanent the staining
of biocytin-loaded cells.
In another set of experiments for combined optical and electrical recordings, the tip of the recording electrode was filled either with a solution of 2 mmol/L fura-2 (pentapotassium salt; Molecular Probes) in 1 mol/L KCl or with 1 containing 5 mmol/L SBFI (tetrammonium salt; Molecular Probes) in 1 mol/L KCl. The shank of the recording electrode was backfilled with a 2-mol/L KCl solution. After cell impalement, cells were loaded with fura-2 or with SBFI by injecting 0.1 to 0.5 nA negative current for 10 to 15 minutes. An Axoclamp 2A amplifier was used for electrophysiology. Traces were displayed on an oscilloscope and stored on a digital system. In the single-electrode voltage-clamp mode, switching frequency is 3 kHz. The head-stage signal was continuously monitored on a separate oscilloscope. The recording chamber was mounted on the stage of an upright microscope (Axioskop FS; Zeiss), equipped with a 60x water immersion objective (Olympus). Fluorescence of SBFI or fura-2 was excited by epi-illumination with light provided by a 75 W xenon lamp bandpass-filtered alternatively at 340 or 380 nm. Emission light passed a barrier filter (500 nm) and was detected by a charge-coupled device camera (Photonic Science). Pairs of 340 and 380 nm images were acquired at intervals of 12 seconds and analyzed off-line with software (IonVision; ImproVision) running on a PowerMac 8100 (Apple Computer). Ratio images were calculated from pairs of 340 and 380 nm images corrected for background fluorescence (measured from regions free of dye fluorescence). Time courses of ratio values were calculated from regions that include the cell bodies (with "regions of interest" defined as those pixels that exhibit at least 20% to 30% of maximal specific fluorescence). Ratio values were transformed into ion concentration with the method of Grynkiewicz et al.15 The calibration parameters Rmin and Rmax for the transformation of SBFI4 and fura-2 signals were obtained in situ by bathing perforated (nystatin and gramicidin D or ionomycin, respectively) cells in Na+-free or Ca2+-free (1 mmol/L EGTA) solution and in 140 mmol/L Na+ and 1 mmol/L Ca2+, respectively, containing solution. In 3 perforated cells, extracellular Na+ concentration was systematically changed (by substitution of NaCl with KCl) to obtain ratio values corresponding to known Na+ concentrations. The apparent Kd values15 for fura-2 are estimated by measuring fluorescence ratios obtained from a solution containing fura-2 and known concentrations of free Ca2+ (Fura-2 Calcium Imaging Calibration Kit, Molecular Probes) trapped between 2 coverslips spaced by pieces of coverslips, and imaged with the water immersion objective. A corresponding approach was used to estimate the Kd of SBFI with calibration solution containing 1 mmol/L EGTA, 0.1 mmol/L CaCl2, 2 mmol/L MgCl2, 10 mmol/L HEPES, 0 to 145 mmol NaCl, and 145 to 0 mmol potassium gluconate ([K+]+[Na+]=145 mmol/L, pH 7.4). This in vitro apparent Kd was consistent with the Kd estimated from perforated cells.
Data Analysis and Drug Applications
Values given in the text and in the figures are mean±SEM of
changes in the respective cell populations. Student's t
test (for paired and unpaired observations) was used to compare the
mean values. The characteristics of action potentials and
current-voltage curves in different experimental conditions were
studied with the use of a fast strip-chart recorder and a digital
system (Nicolet System 400: Benchtop Waveform Acquisition
System; Sekonic). Drugs were applied by dissolving them to the desired
final concentration in the saline and by switching the perfusion from
control saline to drug-containing saline.
6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) was from Tocris.
D-2-amino-5-phosphonovalerate (D-APV), BAPTA, tetrodotoxin (TTX), and
phenytoin were from Sigma. Glibenclamide, nifedipine,
riluzole, saxitoxin, and tolbutamide were from RBI. Lamotrigine and
gabapentin were from Glaxo-Wellcome and Parke-Davis, respectively.
| Results |
|---|
|
|
|---|
) when measured at the resting potential from the amplitude
of small (<10 mV) hyperpolarizing electrotonic pulses, action
potentials of short duration (1.1±0.3 ms), and high amplitudes (102±4
mV). These neurons were silent at rest and showed membrane
rectification and tonic firing activity during depolarizing current
pulses (Figure 1A
|
Effects of Ischemia in Current-Clamp and Voltage-Clamp
Experiments
As shown in Figure 1A
(trace b), glucose and oxygen
deprivation induced a membrane depolarization in striatal
spiny neurons. The amplitude of the ischemia-induced membrane
depolarization was time-dependent. When the slice was exposed to
ischemia for relatively short periods (<6 minutes in most of
the cells, 30 of 33), the membrane depolarization was fully reversible.
Repetitive, brief periods (2 minutes) of ischemia (a 5- to
10-minute interval between each application) caused reproducible
membrane potential changes. The ischemia-induced membrane
depolarization was coupled with a decrease of the input resistance
(Figure 1A
, trace b). This effect persisted also when the
membrane was manually clamped to the resting potential (data not
shown). The amplitude of the ischemic depolarization was
time-dependent (2 minutes: 18±3 mV, n=22; 4 minutes: 45±4 mV, n=25; 6
minutes: 80±2 mV, n=12). Exposure to ischemia for 10 minutes
caused an irreversible membrane depolarization in all the cells tested
(15 of 15; data not shown).
The effect of ischemia on striatal spiny neurons was also
investigated with the single-microelectrode voltage-clamp technique. In
voltage-clamp recordings, glucose and oxygen
deprivation induced an inward current that was coupled with
an increase in membrane conductance as detected by the application of
constant hyperpolarizing voltage steps (1 to 3 seconds' duration, 5 to
15 mV amplitude; Figure 1B
). These events had a time course
similar to that observed in current-clamp experiments. As shown in
Figure 1C
, the extrapolated reversal potential for the
ischemia-induced inward current was 40±4 mV (n=7) with
potassium chloridefilled electrodes. This value was obtained in
voltage-clamp experiments. The cells were clamped at -80 mV, and
voltage steps (1 to 3 seconds' duration) were applied every 10 mV in
depolarizing and hyperpolarizing directions (usually from -110 mV to
-30 mV) under control and ischemic conditions. In 4
experiments we measured the reversal potential of this current by using
potassium acetatefilled electrodes to investigate the possible
contribution of intracellular chloride. The reversal potential obtained
in these experiments was not significantly different from the 1
measured with potassium chloridefilled electrodes (-39±4 mV).
Effects of Ischemia on [Na+]i and
[Ca2+]i
In some experiments (n=7) the cells were injected with fura-2, and
electrical recordings were combined with measurements of
[Ca2+]i. In these
experiments a fixed period (4 minutes) of ischemia was applied.
As shown in Figure 2A
, the
ischemia-induced membrane depolarization started 30 to 60
seconds after the interruption of the oxygen- and glucose-containing
solution and increased progressively during the period of
ischemia. After interruption of the ischemic period the
membrane potential returned to the control level within 2 to 3 minutes.
Figure 2B
shows that the rise in
[Ca2+]i was slow and
progressive. The peak
[Ca2+]i after 4 minutes
of ischemia was 127±22.3 nmol/L. In 8 other experiments, the
cells were injected with SBFI for combined
electrophysiological and
[Na+]i analysis.
The time course of the changes in
[Na+]i was similar to the
time course observed for the membrane depolarization (Figure 2C
). The peak
[Na+]i, after 4 minutes
of ischemia, was 36.5±5 mmol/L. It is noteworthy that on
washout of the ischemic solution,
[Ca2+]i levels returned
promptly to the basal values within 2 minutes, whereas
[Na+]i was still
significantly increased after the same period of washout (Figure 2B
, 2C
). The return of
[Na+]i to resting values
was closely related to the time course of membrane repolarization
(Figure 2A
, 2C
). Because the amplitude and time course of
the ischemia-induced membrane depolarizations measured in the
experiments with the 2 dyes were similar, the data were pooled and
plotted as shown in Figure 2A
.
|
Effects of Low-Ca2+/High-Mg2+ Solutions and
Intracellular BAPTA on Ischemia-Induced Membrane
Depolarizations
Because the ischemic depolarization was coupled with a
significant increase in
[Ca2+]i, we
analyzed the effect of ischemia in a medium containing
low Ca2+ (0.5 mmol/L) and high
Mg2+ (10 mmol/L), which is known to reduce
the influx of Ca2+ into the recorded cell by
decreasing the entry of Ca2+ via
voltage-activated channels and by blocking the excitatory
synaptic transmission. Incubation of the slices in
low-Ca2+/high-Mg2+
solutions did not reduce the ischemia-induced membrane
depolarization (n=5, P>0.05; Figure 3A
). Moreover, the dependence of the
ischemia-induced membrane depolarization/inward current on
[Ca2+]i was studied with
microelectrodes filled with the Ca2+-chelating
agent BAPTA (200 mmol/L). In BAPTA-injected spiny neurons, the
ischemic depolarization was not affected (n=5;
P>0.05; Figure 3A
). Because spiny neurons do not
possess a prominent Ca2+-activated
afterhyperpolarization,8 the
effectiveness of the BAPTA treatment was confirmed by the finding that
the tetanus-induced long-term depression was blocked in these
cells.20
|
Effects of TTX and Low-Na+--Containing Solutions on
Ischemia-Induced Depolarization
Because TTX blocks voltage-activated
Na+ channels and the synaptic transmission
mediated by action potential discharge, we measured the effects of
ischemia on the membrane potential of spiny neurons before and
after the incubation of the slice with this toxin. In the presence of
1 µmol/L TTX, corticostriatal synaptic transmission was
completely abolished, but this Na+-channel
blocker did not affect the membrane depolarization/inward current
described in spiny cells under ischemic conditions (n=6;
P>0.05; Figure 3A
). We also found that 0.3 to 1
µmol/L saxitoxin, an extremely potent
Na+-channel blocker in nanomolar
concentrations,25 did not alter the ischemic
depolarization (n=3; data not shown). The possible involvement of a
TTX-resistant Na+ influx in the
ischemic depolarization/inward current was studied in
low-Na+containing solutions (38 mmol/L;
see Materials and Methods). The lowering of the extracellular
Na+ significantly reduced the
ischemia-induced membrane depolarization and inward current
(n=6; P<0.01; Figure 3A
).
Antagonists of Glutamate Receptors and Neuroprotective
Drugs on Ischemic Depolarization and Corticostriatal
Transmission
During ischemia the release of excitatory amino acids may
also occur via a "nonsynaptic" mechanism that is
Ca2+-independent and insensitive to
TTX.26 Thus, we also tested whether the direct blockade of
postsynaptic glutamate receptors could affect ischemia-induced
membrane depolarization. We incubated (10 minutes before the onset of
ischemia) the slices in 10 µmol/L CNQX, an
antagonist of AMPA glutamate receptors, plus 50
µmol/L APV, an antagonist of NMDA glutamate receptors.
Even under this experimental condition, ischemia caused
membrane depolarizations whose amplitude and duration were similar to
those observed in control medium (n=6; P>0.05; Figure 3B
). These concentrations of glutamate antagonists
fully blocked excitatory postsynaptic potentials (EPSPs) evoked by the
activation of glutamatergic corticostriatal fibers in brain slice
preparations (Figure 3C
).11 20
Blockers of high voltageactivated Ca2+
channels have been reported to reduce the neuronal vulnerability to
ischemia27 and the ischemic depolarization
in cortical neurons.2 Thus, we also studied the effect of
preincubation of the slices in 10 µmol/L nifedipine
on the ischemic depolarization. This L-type
Ca2+-channel blocker was not able to affect the
membrane depolarization/inward current observed under ischemic
conditions (n=4; P>0.05; Figure 3B
) or the
corticostriatal EPSP (Figure 3C
). It has recently been proposed
that antiepileptic drugs may protect central neurons during
ischemic/hypoxic insults because it has been shown that these
drugs inhibit voltage-dependent Na+ and
Ca2+ channels.3 28 29 30 31 32 For this
reason, we tested the effects of the following antiepileptic drugs on
ischemia-induced membrane depolarization: gabapentin (300
µmol/L; n=4), lamotrigine (100 µmol/L; n=5), and phenytoin
(100 µmol/L; n=5). None of these drugs reduced ischemic
depolarization (P>0.05; Figure 3B
), but they reduced
the corticostriatal EPSPs (Figure 3C
). We also tested the effect
of riluzole, a drug that has been shown to block voltage-dependent
Na+ channels and to act as a neuroprotective
agent in neurodegenerative disorders and in some experimental models of
in vivo and in vitro ischemia,33 34 35 36 on
ischemic depolarization. Riluzole (50 µmol/L; n=5)
reduced the EPSP amplitude (Figure 3C
) and failed to affect the
depolarization caused by ischemia (Figure 3B
).
Effects of ATP-Dependent K+ Channel Blockers on
Ischemic Depolarization
To investigate the possible involvement of ATP-dependent
K+ conductances in the membrane potential changes
caused by energy failure in spiny neurons, we studied the effects of
ischemia after the preincubation of the slices either in
tolbutamide or in glibenclamide, blockers of ATP-dependent
K+ channels.6 37 Preincubation in
tolbutamide significantly increased the membrane depolarization/inward
current after ischemic exposure (Figure 4A
, 4C
, traces a and b). As shown in
Figure 4A
, this effect was dose-dependent (100 µmol/L,
n=5, P<0.05; 300 µmol/L, n=5, P<0.01;
1000 µmol/L, n=5, P<0.001). Similar findings were
obtained with glibenclamide, which also enhanced ischemic
depolarization in a dose-dependent manner (30 µmol/L, n=4,
P<0.05; 100 µmol/L, n=4, P<0.01;
300 µmol/L, n=4, P<0.001; Figure 4B
, 4C
, traces c and d). The resting membrane potential and the input
resistance of the cells were not affected by tolbutamide (n=18;
P>0.05) or glibenclamide (n=15; P>0.05) at the
concentrations used in the aforementioned experiments. Moreover, the
effect of ATP-dependent K+-channel blockers was
not coupled to significant changes of the I-V relationship measured in
voltage-clamp experiments. In these experiments, the cells were clamped
at 85 mV, and voltage-steps (0.5 to 3 seconds' duration) were
applied every 10 mV in depolarizing and hyperpolarizing directions
(usually from 115 to 55 mV) under control conditions and during the
drug administration (n=4, Figure 5A
and
n=4, Figure 5B
, respectively).
|
|
| Discussion |
|---|
|
|
|---|
Moreover, neither the lowering of Ca2+ in the external medium nor the intracellular injection of BAPTA, a Ca2+-chelating agent affected the ischemic membrane depolarization. These observations suggest that the rise in [Ca2+]i might have an important function in ischemia-induced "delayed neuronal death"1 but not in the ischemic depolarization observed in striatal spiny neurons. We have recently reported that nifedipine, an L-type Ca2+-channel blocker, significantly decreased the membrane depolarization and the rise in [Ca2+]i measured in cortical neurons during ischemia.2 This drug failed to alter the ischemic depolarization recorded in striatal spiny neurons, indicating that the mechanisms underlying the ischemic depolarization are cell-type specific. On the other hand, we observed that the lowering of Na+ in the external medium produced a significant reduction of ischemic depolarization, suggesting that Na+ influx makes a major contribution to this early electrophysiological event. Blockade of voltage-gated Na+ channels either by TTX or by saxitoxin did not mimic the effect of low Na+. The latter finding indicates that in spiny neurons the rise in [Na+]i induced by ischemia was not due to toxin-sensitive non-inactivating Na+ channels.3 Accordingly, pretreatment with various putative neuroprotective agents such as phenytoin, lamotrigine, gabapentin, and riluzole, which have been shown to act as blockers of Na+ channels, significantly decreased synaptic transmission but failed to reduce ischemic depolarization.
The positive effect of low extracellular Na+ and the lack of effect of TTX, low extracellular Ca2+, and glutamate receptor antagonists on membrane depolarization in striatal spiny neurons are consistent with previous observations in other neuronal cell types during anoxia.39 40 The experiments with TTX and low external Ca2+ seem to rule out the involvement of a "classic synaptic" release of excitatory transmitters in the ischemic depolarization. Nevertheless, a "nonsynaptic" release of glutamate that is insensitive to TTX and Ca2+-independent has been described during ischemia.26 Such a release might contribute to the ischemic depolarization. However, the lack of effect of ionotropic glutamate receptor antagonists on this electrophysiological effect makes this possibility unlikely.
On the basis of the extrapolated I-V curve, the reversal potential for the ischemia-induced responses in spiny neurons is approximately 40 mV (KCl electrodes). This value is very close to the reversal potential for aglycemia and hypoxia in these cells and suggests that common ionic mechanisms underlie these events.11 12 Accordingly, a nonselective cation conductance with the contribution of Na+ and K+ ions might be responsible for the ischemia-induced electrical changes recorded in striatal spiny neurons and for those induced by aglycemia. It is also possible that a critical contribution to the rise of [Na+]i during oxygen and glucose deprivation is made by an impaired activity of Na+,K+-ATPase. In fact, this electrogenic pump extrudes 3 Na+ ions for 2 K+ ions and for this activity requires an adequate ATP supply whose production is defective during ischemia.
A further piece of evidence in favor of a K+ conductance taking part in this electrophysiological phenomenon is represented by the effects of tolbutamide and glibenclamide. These blockers of ATP-dependent K+ channels6 37 significantly increase the membrane depolarization/inward current after ischemic exposure. The I-V relationship of the recorded cells was not altered by the concentrations of blockers used in the present experiments. Thus, we can argue that the facilitatory effects of tolbutamide and glibenclamide on the ischemic depolarization are related to the blockade of ATP-dependent K+ channels rather than to an aspecific increase of the neuronal input resistance. The ATP-dependent K+ channels are activated by the depletion of ATP that occurs during energy failure. During the ischemic insult, these conductances allow an efflux of K+ ions that counterbalance the main driving force of Na+ ions that by entering the cell cause the recorded membrane depolarization. Thus, the blockade of ATP-dependent K+ conductances would enhance the ischemic depolarization in striatal spiny neurons. It should be noted, however, that high concentrations of tolbutamide (100 to 1000 µmol/L) and glibenclamide (30 to 300 µmol/L) are required to achieve this effect. In peripheral tissue (ie, pancreas, heart, and vascular smooth muscle) glibenclamide in the low micromolar range is generally adequate to inhibit ATP-dependent K+ channels. Both high- and low-affinity binding sites for glibenclamide have been described in the rat brain.41 Compared with peripheral tissue, relatively high concentrations of glibenclamide and tolbutamide have been used by others to study oxygen-deprived neurons.42 43 Thus, the ATP-dependent K+ channel in neurons is presumably different from that in peripheral tissue. Nevertheless, the effect of glibenclamide on rubidium efflux and on extracellular K+ activity is maximum at 10 to 20 µmol/L.42 44 The present observations that augmentation of membrane depolarization does not start until 30 µmol/L glibenclamide raises the possibility of a nonspecific effect on other K+ channels.
Future studies are in progress in our laboratory to further characterize the ionic changes underlying the ischemic depolarization in striatal spiny neurons and in other neuronal subtypes within this structure. These studies might help to understand the mechanisms responsible for cell-typespecific vulnerability to ischemia in the striatum.
| Acknowledgments |
|---|
Received August 27, 1998; revision received October 26, 1998; accepted October 26, 1998.
| References |
|---|
|
|
|---|
Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland
| Introduction |
|---|
|
|
|---|
In the present study, Calabresi et al used a wide range of pharmacological probes to distinguish which channels may contribute to depolarization of striatal spiny neurons known to be vulnerable to ischemia. Using a brain slice preparation, they found that depolarization from oxygen-glucose deprivation was reduced by lowering external Na+ but not by lowering external Ca2+. However, a variety of drugs that block Na+ channels were ineffective in reducing the anoxic depolarization. These results agree to some extent with in vivo work in the cortex in which some drugs that affect Na+ conductance could delay anoxic depolarization.5 Thus, we are left with several possibilities. First, Na+ entry is important, but no single channel subtype is predominant because conductance increases substantially in multiple subtypes of voltage-dependent and ligand-operated Na+ channels. In this case, blocking 1 type of Na+ channel has little bearing on the depolarization amplitude. Thus, fast-activating voltage-dependent Na+ channels may contribute to the inward Na+ current6 without having a major impact on the eventual magnitude of depolarization. Second, Na+ entry during anoxic depolarization may occur nonspecifically through the opening of other large pores not antagonized by the presently used regimen of drugs. Neither explanation is particularly satisfying, and further work with more refined probes and careful analysis of the depolarization-time trajectory is required.
Another finding of the present study is that nifedipine failed to attenuate the depolarization amplitude in striatal spiny neurons. This result is in contrast to previous work from this laboratory in which L-type Ca2+ channel blockers reduced the increase in intracellular Ca2+ and the magnitude of anoxic depolarization in cortical pyramidal neurons.7 Together, these results emphasize the diversity of involvement of different ionic channels in anoxic depolarization among different cell types.
A third finding is that ATP-sensitive K+ (KATP)-channel antagonists augment anoxic depolarization. These results imply that opening of KATP channels during ischemia limits the magnitude of depolarization. However, some caution should be exercised because rather high concentrations of glibenclamide and tolbutamide were required, thereby raising the concern of nonspecificity. Nevertheless, others have shown that high-dose glibenclamide limits the maximum increase in extracellular K+ in anoxic cortex in vivo.5
Last, there are some potential limitations in applying the results from the brain slice preparation to the in vivo situation. First, spontaneous electrical activity is suppressed in brain slices. Thus, some of the changes in ionic conductance normally associated with the loss of electroencephalographic activity before anoxic depolarization may be absent in the slice preparation. Moreover, because of the lower metabolic rate associated with a loss of electrical activity, the rate of ATP depletion may be slower and the sequence of ionic channel opening may be altered. Second, the bathing solution surrounding the slice provides an additional source of Na+, Ca2+, and water and an additional sink for K+ channels that are not normally present in vivo. Third, harvesting tissue for the brain slice preparation in itself produces transient ischemia. Because a change in phospholipids and ATP may alter the characteristics of ionic channels,6 8 their functioning during subsequent oxygen-glucose deprivation may be modified. Thus, some caution should be taken in interpreting the lack of effect of Na+-channel blockers in the present study.
Received August 27, 1998; revision received October 26, 1998; accepted October 26, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Chao, A. Bazzy-Asaad, G. Balboni, S. Salvadori, and Y. Xia Activation of DOR Attenuates Anoxic K+ Derangement via Inhibition of Na+ Entry in Mouse Cortex Cereb Cortex, January 17, 2008; (2008) bhm247v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Fernandez, P. Ortega-Saenz, A. Castellano, and J. Lopez-Barneo Mechanisms of Low-Glucose Sensitivity in Carotid Body Glomus Cells Diabetes, December 1, 2007; 56(12): 2893 - 2900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tortiglione, B. Picconi, I. Barone, D. Centonze, S. Rossi, C. Costa, M. Di Filippo, A. Tozzi, M. Tantucci, G. Bernardi, et al. Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area Stroke, May 1, 2007; 38(5): 1614 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bao, M. V. Avshalumov, and M. E. Rice Partial Mitochondrial Inhibition Causes Striatal Dopamine Release Suppression and Medium Spiny Neuron Depolarization via H2O2 Elevation, Not ATP Depletion J. Neurosci., October 26, 2005; 25(43): 10029 - 10040. [Abstract] [Full Text] [PDF] |
||||
![]() |